LPI/GPR55系统通过激活ACC促进非酒精性脂肪性肝病进展
该研究探讨GPR55及其配体LPI在非酒精性脂肪性肝病中的作用。在NASH患者中循环LPI和肝脏GPR55表达上调,LPI通过激活ACC促进新生脂肪生成并抑制β氧化,增加肝细胞脂质含量;抑制GPR55或ACCα可阻断LPI效应,敲低GPR55可改善高脂饮食及MCD饮食小鼠肝损伤。
要点
- NASH患者循环LPI和肝脏GPR55表达上调
- LPI通过GPR55激活ACC促进脂肪生成并抑制β氧化
- 抑制GPR55或ACCα可阻断LPI效应,敲低GPR55改善小鼠肝损伤
核心结论
- LPI/GPR55系统通过激活ACC参与NAFLD和NASH的发生发展。
研究设计与样本
- 研究检测了NAFLD患者及脂肪变和NASH动物模型的肝脏GPR55表达,并评估LPI及GPR55基因敲除在人肝细胞、人肝星状细胞和小鼠中的效应。
主要发现
- NASH患者循环LPI和肝脏GPR55表达上调。
- LPI通过诱导新生脂肪生成和减少β氧化,增加人肝细胞和处理小鼠肝脏的脂质含量。
- 抑制GPR55和ACCα可阻断LPI的效应;体内敲低GPR55可改善高脂饮食和MCD饮食小鼠的肝损伤。
- LPI通过刺激GPR55和激活ACC促进肝星状细胞活化的启动。
临床怎么用
- LPI/GPR55/ACC轴可能作为NAFLD和NASH的潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: G protein-coupled receptor (GPR) 55 is a putative cannabinoid receptor, and l-α-lysophosphatidylinositol (LPI) is its only known endogenous ligand. Although GPR55 has been linked to energy homeostasis in different organs, its specific role in lipid metabolism in the liver and its contribution to the pathophysiology of nonalcoholic fatty liver disease (NAFLD) remains unknown. APPROACH AND RESULTS: We measured (1) GPR55 expression in the liver of patients with NAFLD compared with individuals without obesity and without liver disease, as well as animal models with steatosis and nonalcoholic steatohepatitis (NASH), and (2) the effects of LPI and genetic disruption of GPR55 in mice, human hepatocytes, and human hepatic stellate cells. Notably, we found that circulating LPI and liver expression of GPR55 were up-regulated in patients with NASH. LPI induced adenosine monophosphate-activated protein kinase activation of acetyl-coenzyme A carboxylase (ACC) and increased lipid content in human hepatocytes and in the liver of treated mice by inducing de novo lipogenesis and decreasing β-oxidation. The inhibition of GPR55 and ACCα blocked the effects of LPI, and the in vivo knockdown of GPR55 was sufficient to improve liver damage in mice fed a high-fat diet and in mice fed a methionine-choline-deficient diet. Finally, LPI promoted the initiation of hepatic stellate cell activation by stimulating GPR55 and activation of ACC. CONCLUSIONS: The LPI/GPR55 system plays a role in the development of NAFLD and NASH by activating ACC.
引用
- Fondevila MF, Fernandez U, Gonzalez-Rellan MJ, et al. The L-α-Lysophosphatidylinositol/G Protein-Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis. Hepatology. 2020. PMID: 32329085. doi:10.1002/hep.31290
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。